Cite
HARVARD Citation
Chen, D. et al. (2018). HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9. Therapeutic advances in medical oncology. p. . [Online].